Common-Size Income Statement
Paying user area
Try for free
Johnson & Johnson pages available for free this week:
- Income Statement
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Johnson & Johnson for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Johnson & Johnson, common-size consolidated income statement
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Income statement item | Description | The company |
|---|---|---|
| Operating earnings | The net result for the period of deducting operating expenses from operating revenues. | Johnson & Johnson operating earnings as a percentage of sales to customers increased from 2022 to 2023 but then decreased significantly from 2023 to 2024. |
| Earnings before provision for taxes on income | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Johnson & Johnson earnings before provision for taxes on income as a percentage of sales to customers decreased from 2022 to 2023 but then slightly increased from 2023 to 2024. |
| Net earnings | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Johnson & Johnson net earnings as a percentage of sales to customers increased from 2022 to 2023 but then decreased significantly from 2023 to 2024. |